Pulling SEC filings + quote and writing the call…

OMEGA HEALTHCARE INVESTORS INC
Next earnings Jul 29, 2026 · consensus $0.48 EPS, $305M rev
Last earnings +1.6% on 2026-04-28
Recovering SNF-focused REIT with rising revenue and a deleveraged balance sheet, but the $780M dividend outruns net income.
Revenue $1.19B · FY2025
Middling fundamentals offset by an attractive price (~49% below fair value) — worth a look on the value angle.
Omega Healthcare Investors is a skilled-nursing-facility (SNF) and assisted-living REIT that has staged a clear recovery. FY2025 revenue grew 13.2% to $1.19B and net income jumped 45.2% to $590M, with diluted EPS up 25.2% to $1.94, extending a turnaround from the COVID-era trough. As a REIT the relevant cash measure is operating cash flow, which rose 17.2% to $879M — strong coverage that funds the business and most of the dividend. Operating margin of 46.4% and net margin of 49.6% reflect the high-margin triple-net lease model across 1,027 facilities operated by 89 third-party operators.
The balance sheet has improved markedly: total liabilities fell 10.8% to $4.61B and long-term debt dropped 12.0% to $4.26B, while equity rose 14.2% to $5.18B, leaving a conservative 0.89x liabilities-to-equity ratio. The newly adopted RIDEA structure (begun Q4 2025) lets Omega capture operating upside at select facilities beyond fixed rents, a potential growth lever.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:45 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.06B | $878M | $950M | $1.05B | $1.19B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | — | — | $242M | $406M | $590M |
| Diluted EPS | $1.75 | $1.80 | $1.00 | $1.55 | $1.94 |
| Net margin | — | — | 25.5% | 38.6% | 49.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0000888491, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 6/21/2026, 8:45:00 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-07-01 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 168.00 @ $37.25 | $6.26K |
| 2026-07-01 | Ballew Neal CHIEF ACCOUNTING OFFICER | Disposed (D) | 11.00 @ $47.68 | $524.48 |
| 2026-06-05 | WHITMAN BURKE W Director | Award | 3.78K @ $43.67 | $165K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1194 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.